Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
Del Prete E, Francesconi A, Palermo G, Mazzucchi S, Frosini D, Morganti R, Coleschi P, Raglione LM, Vanni P, Ramat S, Novelli A, Napolitano A, Battisti C, Giuntini M, Rossi C, Menichetti C, Ulivelli M, De Franco V, Rossi S, Bonuccelli U, Ceravolo R; Tuscany Parkinson COVID-19 Participants. Del Prete E, et al. Among authors: menichetti c. J Neurol. 2021 Apr;268(4):1179-1187. doi: 10.1007/s00415-020-10002-6. Epub 2020 Sep 3. J Neurol. 2021. PMID: 32880722 Free PMC article.
A magnetization transfer study of mild and advanced Parkinson's disease.
Tambasco N, Belcastro V, Sarchielli P, Floridi P, Pierguidi L, Menichetti C, Castrioto A, Chiarini P, Parnetti L, Eusebi P, Calabresi P, Rossi A. Tambasco N, et al. Among authors: menichetti c. Eur J Neurol. 2011 Mar;18(3):471-7. doi: 10.1111/j.1468-1331.2010.03184.x. Epub 2010 Aug 16. Eur J Neurol. 2011. PMID: 20722713
Impulsivity traits and awareness of motor intention in Parkinson's disease: a proof-of-concept study.
Giovannelli F, Menichetti C, Kiferle L, Raglione LM, Brotini S, Vanni P, Bacci D, Baldini M, Borgheresi A, Del Bene A, Grassi E, Guidi L, Toscani L, Volpi G, Palumbo P, Viggiano MP, Cincotta M. Giovannelli F, et al. Among authors: menichetti c. Neurol Sci. 2022 Jan;43(1):335-340. doi: 10.1007/s10072-021-05325-9. Epub 2021 May 28. Neurol Sci. 2022. PMID: 34050422
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.
Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R, Pisani F, Rossi A, Calabresi P, Tambasco N. Belcastro V, et al. Among authors: menichetti c. Eur J Neurol. 2010 May;17(5):661-5. doi: 10.1111/j.1468-1331.2009.02894.x. Epub 2009 Dec 27. Eur J Neurol. 2010. PMID: 20050890
Intracerebral hemorrhage location and outcome among INTERACT2 participants.
Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS; INTERACT2 Investigators. Delcourt C, et al. Neurology. 2017 Apr 11;88(15):1408-1414. doi: 10.1212/WNL.0000000000003771. Epub 2017 Feb 24. Neurology. 2017. PMID: 28235817 Free PMC article. Clinical Trial.
Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.
Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group. Mair G, et al. Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9. Neurology. 2016. PMID: 26658907 Free PMC article. Clinical Trial.
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group. Sandercock P, et al. Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252. Trials. 2011. PMID: 22129158 Free PMC article. Clinical Trial.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
27 results